Atrial fibrillation following device closure of patent foramen ovale

被引:43
作者
Burow, Annika [1 ]
Schwerzmann, Markus [1 ]
Wallmann, Dieter [1 ]
Tanner, Hildegard [1 ]
Sakata, Takao [1 ]
Windecker, Stephan [1 ]
Meier, Bernhard [1 ]
Delacretaz, Etienne [1 ]
机构
[1] Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, FESC, CH-3010 Bern, Switzerland
关键词
patent foramen ovale; paradoxical embolism; cryptogenic stroke; arrhythmias; long-time ECG recording;
D O I
10.1159/000113427
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives: Recurrent embolic events after device closure of patent foramen ovale (PFO) have been related to incomplete closure. Another cause could be atrial fibrillation (AF). The aim of this study was to determine the incidence of AF in stroke patients after PFO closure. Methods: Consecutive patients with device closure of a PFO after a stroke or transient ischemic attack and control patients with stroke underwent 7-day event loop recordings 3 and 6 months after PFO closure or stroke, respectively. Results: Forty patients treated by PFO device closure 96 8 68 days after cryptogenic ischemic stroke and 70 control patients with ischemic stroke of other etiologies (known AF excluded) were compared. AF was identified in 6 patients (15%) of the treated group and in 12 control patients (17%, p = 0.77). In multivariate analysis, the presence of an occluder device was not an independent risk factor for AF. Conclusions: The incidence of AF is high after device closure of a PFO in stroke patients and similar to that in patients with stroke of non-PFO etiology and, hence, with no device. Further studies are required to determine the risk of thromboembolism and the optimal treatment in patients developing AF after device closure of a PFO. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 9 条
[1]
Alaeddini Jamshid, 2006, J Invasive Cardiol, V18, P365
[2]
Interventional closure of patent foramen ovale and atrial septal defects after paradoxical embolic events [J].
Beitzke, A ;
Schuchlenz, H ;
Beitzke, M ;
Gamillscheg, A ;
Stein, HI ;
Zartner, P .
ZEITSCHRIFT FUR KARDIOLOGIE, 2002, 91 (09) :693-700
[3]
Braun MU, 2002, Z KARDIOL, V91, P659, DOI 10.1007/s00392-002-0820-4
[4]
Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke [J].
Giardini, A ;
Donti, A ;
Formigari, R ;
Salomone, L ;
Palareti, G ;
Guidetti, D ;
Picchio, FM .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (04) :625-629
[5]
Stroke recurrence and its prevention in patients with patent Foramen ovale [J].
Harrer, JU ;
Wessels, T ;
Franke, A ;
Lucas, S ;
Berlit, R ;
Klötzsch, C .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2006, 33 (01) :39-47
[6]
Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer® septal occluder [J].
Hill, SL ;
Berul, CI ;
Patel, HT ;
Rhodes, J ;
Supran, SE ;
Cao, QL ;
Hijazi, ZM .
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2000, 4 (03) :469-474
[7]
Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli - A systematic review [J].
Khairy, P ;
O'Donnell, CP ;
Landzberg, MJ .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (09) :753-760
[8]
Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder [J].
Spies, C ;
Strasheim, R ;
Timmermanns, I ;
Schraeder, R .
EUROPEAN HEART JOURNAL, 2006, 27 (03) :365-371
[9]
Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke [J].
Windecker, S ;
Wahl, A ;
Nedeltchev, K ;
Arnold, M ;
Schwerzmann, M ;
Seiler, C ;
Mattle, HP ;
Meier, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (04) :750-758